Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : How To Write Covered Calls - An Ongoing Real Case Study! -- Ignore unavailable to you. Want to Upgrade?

To: rkf who wrote (6439)	1/15/1998 9:23:00 AM
From: Herm	Respond to of 14162

There will be some good opportunities along the way as VVUS releases positive news. Expansion into Asia, UK, and United States backed up by the increased production capabilities (upon FDA approval) and a major worldwide media blitz should generate additional revenues in no time. The VVUS stock buy back program if coordinated and done right could ignite a MAJOR short squeeze aided by the major shareholders (institutions and mutual funds) that would smell the blood and average down their major holdings for quick profits! They will have to sell into the buying in order to walk away with an overall profit for all of their shares. The stock is way under valued at this point. Regardless of the eventual release of oral pill alternatives there is bound to be a VVUS comeback to the $40 - $50 range early this year. What happens after that is unknown! It would be much easier for management to influence the street with an enhanced track record if they sucessfully pulls off this comeback! It won't be boring for sure.